Article: Technology Pioneer 2009 - AC Immune Highlights Significant Clinical Milestones in Alzheimer's Disease Drug Development.

Article: AC Immune Raises CHF 21 Million in Private ...
PR Newswire;  May 11, 2005 ;     700+ words ... ... Switzerland, May 11 /PRNewswire/ -- AC Immune, a Swiss biotech company developing ... capital contributed by new investors. AC immune is focused on new therapies for the treatment ... patent-protected antigen technology of AC Immune provides highly efficient immunization ...

Article: Genentech and AC Immune: Exclusive License ...
PR Newswire Europe;  December 7, 2006 ;     700+ words ... ... Switzerland, December 7 /PRNewswire/ -- - AC Immune, Ltd. Enters Into an Exclusive Global ... s Disease and Other Human Diseases. AC Immune, Ltd., a Swiss Biotech Company developing ... modification of Alzheimer's disease and AC Immune has developed conformation-specific ...

Article: AC Immune Identifies Clinical Lead Compounds for ...
PR Newswire;  March 8, 2006 ;     700+ words ... ... Switzerland, March 8 /PRNewswire/ -- AC Immune, a Swiss Biotech Company developing ... the memory function in animal studies. AC Immune's proprietary therapeutic approach ... The results also provided proof of AC Immune's key technology for active and passive ...

Article: AC Immune Signs First Major Antibody Deal, With ...
BIOWORLD Today;  December 8, 2006 ;     700+ words ... ... Inc. worth more than $300 million. AC Immune Ltd. entered the exclusive global license ... CEO and a co-founder, who described AC Immune's position as a "paradise" for a ... respectively. Under the agreement with AC Immune, Genentech will make an undisclosed ...

Article: AC Immune SA.(Financing)(Brief article)
MondayMorning;  February 2, 2009 ;     700+ words ...Swiss independent biotech group AC Immune SA is open to being bought if it were ... remaining independent," Pfeifer said. AC Immune, which develops drugs for Alzheimer ... million francs in three rounds since AC Immune was founded in 2003," AC Immune said ...

Article: AC Immune/Genentech sign AD R&D deal worth up to ...
Pharma Marketletter;  December 22, 2006 ;     676 words ...Swiss biotechnology firm AC Immune has entered an exclusive global license ... important target for AD modification and AC Immune has developed conformation-specific ... Genentech will make an upfront payment to AC Immune, with the potential for a total ...

Article: Bayer to collaborate with Swiss AC Immune in ...
ADP News Germany;  October 8, 2009 ;     602 words ... ... Pharma will co-operate with Swiss peer AC Immune SA in a study on Alzheimer's disease ... emission tomography (PET) tracer, to AC Immune to support a study aimed at the development ... of Alzheimer's vaccine ACI-24 of AC Immune. The PET tracer will be tested for the ...